Short-lasting unilateral neuralgiform headache with conjuntival injection and tearing (SUNCT) syndrome is a rare trigeminal autonomic cephalalgia. We report a patient with prolactinoma and cabergoline-induced SUNCT attacks and the literature is reviewed for a better understanding of the pathophysiology.
Headache Classification Committee of the International Headache Society.The International Classification of Headache Disorders, 2nd edition. Cephalalgia2004; 24 (Suppl.):1–160.
2.
PenartAFirthMBowenJR. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) following presumed dorsolateral brainstem infarction. Cephalalgia2001; 21:236–9.
3.
LevyMJMatharuMSMeeranKPowellMGoadsbyPJ. The clinical characteristics of headache in patients with pituitary tumors. Brain2005; 128:1921–30.
LevyMJMatharuMSGoadsbyPJ. Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol2003; 10:169–73.
6.
AbeTMatsumotoKKuwazawaJToyodaISasakiK. Headache associated with pituitary adenomas. Headache1998; 38:782–6.
7.
ArafahBMPruntyDYbarraJHlavinMLSelmanWR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab2000; 85:1789–93.
8.
ForsythPAPosnerJB. Headaches in patients with brain tumor: a study of 111 patients. Neurology1993; 43:1678–83.
9.
MoskowitzMA. Cluster headache: evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus. Headache1988; 28:584–6.
10.
Millan GuerreroROIsais CardenasMA. Headache associated with pituitary adenomas. Headache1999; 39:522–3.
11.
LevyMJJagerHRPowellMMatharuMSMeeranKGoadsbyPJ. Pituitary volume and headache: size is not everything. Arch Neurol2004; 61:721–5.
12.
MayABahraABuchelCTurnerRGoadsbyPJ. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol1999; 46:791–4.
13.
MasciaAAfraJSchoenenJ. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia1998; 18:174–82.
14.
FerrariMDHaanJvan SetersAP. Bromocriptine-induced trigeminal neuralgia attacks in a patients with pituitary tumor. Neurology1988; 38:1482–4.
15.
MassiouHLaunayJMLevyCEl AmraniMEmperaugerBBousserMG. SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology2002; 58:1698–9.
16.
TrabucchiMHofmannMMontefuscoOSpanoPF. Ergot alkaloids and cyclic neurotides in the CNS. Pharmacology1978; 16 (Suppl. 1):150–5.
17.
HoskinKLKaubeHGoadsbyPJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain1996; 119:249–56.
